Type II and III receptors for immunoglobulin G (IgG) control the presentation of different T cell epitopes from single IgG-complexed antigens

Journal of Experimental Medicine

Volumn 187, Issue 4, 1998, Pages 505-515

  Amigorena, Sebastian ^a   Lankar, Danielle ^a   Briken, Volker ^a   Gapin, Laurent ^b   Viguier, Mireille ^a   Bonnerot, Christian ^a  

^a INSERM   (France)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYCLOHEXIMIDE; EPITOPE; FC RECEPTOR; IMMUNOGLOBULIN G; LEUCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OVALBUMIN; RECEPTOR SUBTYPE;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; INTERNALIZATION; LYMPHOMA CELL; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ALANINE; ANTIGEN PRESENTATION; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, CD; EPITOPES, T-LYMPHOCYTE; HUMANS; LEUCINE; POINT MUTATION; RECEPTORS, IGG; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0032536534     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.4.505     Document Type: Article

References (40)

1. Germain, R.N., and D.H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403-450.
2. Cresswell, P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259-293.
3. Sercarz, E.E., P.V. Lehmann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:729-766.
4. Lanzavecchia, A. 1990. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu. Rev. Immunol. 8:773-793.
5. Germain, R.N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 76:287-299.
6. Roche, P.A. 1995. HLA-DM: an in vivo facilitator of MHC class II peptide loading. 3:259-262.
7. Reid, P.A., and C. Watts. 1990. Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments. Nature. 346:655-657.
8. Pinet, V., M. Vergelli, R. Martin, O. Bakke, and E.O. Long. 1995. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature. 375:603-606.
9. Guangming, Z., P. Romagnoli, and R.N. Germain. 1997. Related leucine-based cytoplasmic targeting signals in invariant chain and major histocompatibility complex class II molecules control endocytic presentation of distinct determinants in a single protein. J. Exp. Med. 185:429-438.
10. Bonnerot, C., D. Lankar, D. Hanau, D. Spehner, J. Davoust, J. Salamero, and W.H. Fridman. 1995. Role of B cell receptor Ig alpha and Ig beta subunits in MHC class II-restricted antigen presentation. Immunity. 3:335-347.
11. Lanzavecchia, A. 1987. Antigen uptake and accumulation in antigen-specific B cells. Immunol. Rev. 99:39-51.
12. Lanzavecchia, A. 1985. Antigen-specific interaction between T and B cells. Nature. 314:537-539.
13. Amigorena, S., C. Bonnerot, J.R. Drake, D. Choquet, W. Hunziker, J.G. Guillet, P. Webster, C. Sautes, I. Mellman, and W.H. Fridman. 1992. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science. 256:1808-1812.
14. Watts, C., and A. Lanzavecchia. 1993. Suppressive effect of antibody on processing of T cell epitopes. J. Exp. Med. 178: 1459-1463.
15. Simitsek, P.D., D.G. Campbell, A. Lanzavecchia, N. Fairweather, and C. Watts. 1995. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J. Exp. Med. 181:1957-1963.
16. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179:1109-1118.
17. Ravetch, J.V. 1994. Fc receptors: rubor redux. Cell. 78:553-560.
18. Bonnerot, C., S. Amigorena, D. Choquet, R. Pavlovich, V. Choukroun, and W.H. Fridman. 1992. Role of associated gamma-chain in tyrosine kinase activation via murine Fc gamma RIII. EMBO (Eur. Mol. Biol. Organ.) J. 11:2747-2757.
19. Amigorena, S., J. Salamero, J. Davoust, W.H. Fridman, and C. Bonnerot. 1992. Tyrosine-containing motif that transduces cell activation signals also determines internalization and antigen presentation via type III receptors for IgG. Nature. 358:337-341.
20. Weinshank, R.L., A.D. Luster, and J.V. Ravetch. 1988. Function and regulation of a murine macrophage-specific IgG Fc receptor, FcγRα. J. Exp. Med. 167:1909-1925.
21. Jones, B., J.P. Tite, and C.A. Janeway. 1986. Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, IA-resticted T cell clones. J. Immunol. 136: 348-356.
22. Guillet, J.G., M.Z. Lai, T.J. Briner, J.A. Smith, and M.L. Gefter. 1986. Interaction of peptide antigens and class II major histocompatibility complex antigens. Nature. 324:260-262.
23. Lai, M.Z., D.T. Ross, J.G. Guillet, T.J. Briner, M.L. Gefter, and J.A. Smith. 1987. T lymphocyte response to bacteriophage lambda repressor cI protein. Recognition of the same peptide presented by Ia molecules of different haplotypes. J. Immunol. 139:3973-3980.
24. Li, W.F., M.D. Fan, C.B. Pan, and M.Z. Lai. 1992. T cell epitope selection: dominance may be determined by both affinity for major histocompatibility complex and stoichiometry of epitope. Eur. J. Immunol. 22:943-949.
25. Cibotti, R., J.P. Cabaniols, C. Pannetier, C. Delarbre, I. Vergnon, J.M. Kanellopoulos, and P. Kourilsky. 1994. Public and private Vβ T cell receptor repertoires against hen egg white lysozyme (HEL) in nontransgenic versus HEL transgenic mice. J. Exp. Med. 180:861-872.
26. Harper, M., F. Lema, G. Boulot, and R.J. Poljack. 1987. Antigen specific and cross-reactivity of monoclonal anti-lysozyme antibodies. Mol. Immunol. 2:97-108.
27. Justement, L.B., J. Kreiger, and J.C. Cambier. 1989. Production of multiple lymphokines by the A20.1 B cell lymphoma after cross-linking of membrane Ig by immobilized anti-Ig. J. Immunol. 143:881-889.
28. Pinet, V., M.S. Malnati, and E.O. Long. 1994. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. J. Immunol. 152:4852-4860.
29. Lamaze, C., and S.L. Schmid. 1995. Recruitment of epidermal growth factor receptors into coated pits requires their activated tyrosine kinase. J. Cell Biol. 129:47-54.
30. Felder, S., K. Miller, G. Moehren, A. Ullrich, J. Schlessinger, and C.R. Hopkins. 1990. Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body. Cell. 61:623-634.
31. Mellman, I., and H. Plutner. 1984. Internalization and degradation of macrophage Fc receptors bound to polyvalent immune complexes. J. Cell Biol. 98:1170-1177.
32. Castellino, F., and R.N. Germain. 1995. Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded classs II in multiple compartments. Immunity. 2:73-88.
33. Brachet, V., G. Raposo, S. Amigorena, and I. Mellman. 1997. Ii chain controls the transport of major histocompatibility complex class II molecules to and from lysosomes. J. Cell Biol. 137:51-65.
34. Griffin, J.P., R. Chu, and C.V. Harding. 1997. Early endosomes and a late endocytic compartment generate different peptide-class II MHC complexes via distinct processing mechanisms. J. Immunol. 158:1523-1532.
35. Kropshofer, H., A.B. Vogt, G. Moldenhaur, J. Hammer, J.S. Blum, and G.J. Hammerling. 1996. Editing of HLA-DR peptide repertoire by HLA-DM. EMBO (Eur. Mol. Biol. Organ.) J. 15:6144-6154.
36. Amigorena, S., J.R. Drake, P. Webster, and I. Mellman. 1994. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature. 369:113-120.
37. Amigorena, S., P. Webster, J. Drake, J. Newcomb, P. Cresswell, and I. Mellman. 1995. Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J. Exp. Med. 181:1729-1741.
38. + cells. J. Immunol. 152:201-212.
39. Lanzavecchia, A. 1995. How can cryptic epitopes trigger autoimmunity? J. Exp. Med. 181:1945-1948.
40. Salemi, S., A.P. Caporossi, L. Boffa, M.G. Longobardi, and V. Barnaba. 1995. HIVgp120 activates autoreactive CD4-specific T cell responses by unveiling of hidden CD4 peptides during processing. J. Exp. Med. 181:2253-2257.